EDN1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population harboring a targeted disruption of the human EDN1 gene, which encodes the potent vasoactive peptide endothelin-1. This polyclonal pool arises from direct gene editing in the HEK293T host background, yielding a mixed population that collectively eliminates endothelin-1 expression and provides a physiologically relevant loss-of-function model for dissecting endothelin-dependent signaling networks. The knockout cell pool is an essential tool for investigating autocrine and paracrine roles of EDN1 without the confounding influence of clonal artifacts, and it is optimized for high-throughput screening, pathway interrogation, and receptor pharmacology studies.
The host cell line, HEK293T, is a human embryonic kidney epithelial derivative stably expressing the SV40 large T antigen, which permits high-level episomal replication of plasmids containing the SV40 origin of replication. Originally transformed with sheared adenovirus type 5 DNA, these cells are widely recognized for their exceptional transfectability and robust protein expression capacity, making them a workhorse for viral packaging, recombinant protein production, and cell biology assays. Their epithelial origin and renal phenotype further position them as a relevant model for studying kidney physiology and ion transport processes, complementing the interrogation of endothelin-1 functions in renal and vascular contexts.
Endothelin-1 is a multifunctional peptide that exerts its biological effects through two G-protein-coupled receptors, EDNRA and EDNRB, which couple predominantly to Gq/G11, leading to activation of phospholipase C, generation of inositol 1,4,5-trisphosphate and diacylglycerol, intracellular calcium mobilization, and protein kinase C stimulation. This initiates a cascade that includes the MAPK/ERK pathway, culminating in the transcriptional regulation of immediate-early genes such as c-fos and c-jun, as well as downstream targets like COX-2 and VEGF. EDN1 expression is tightly controlled by a range of upstream regulators, including TGF-beta, angiotensin II, thrombin, TNF-alpha, hypoxia, and shear stress, and its signaling is fine-tuned by interactions with caveolin-1 and arrestins, which modulate receptor trafficking and desensitization. The integrated EDN1?CEDNRA/EDNRB axis thus coordinates vasoconstriction, cell proliferation, extracellular matrix deposition, and inflammatory responses, making it a central node in cardiovascular and fibrotic disease mechanisms.
Disruption of EDN1 in the HEK293T background eliminates the endogenous source of this peptide, thereby abrogating its autocrine and paracrine signaling loops. Given that HEK293T cells endogenously express components of the endothelin pathway, this knockout polyclonal pool enables clean dissection of EDN1-dependent functions, such as calcium signaling, MAPK/ERK activation, and gene expression changes, without residual peptide interference. The model is particularly suited for reconstitution studies using wild-type or mutant EDN1 expression constructs, as the lack of endogenous peptide simplifies interpretation of receptor?Cligand interaction assays and downstream effector measurements. Moreover, the epithelial nature of the host cells allows exploration of EDN1??s role in renal epithelial cell function, fibrosis, and proliferation, providing a diseaserelevant context for hypertension and chronic kidney disease research.
This knockout cell product finds application across a spectrum of cardiovascular and fibrotic disease research, including hypertension, pulmonary arterial hypertension, atherosclerosis, heart failure, systemic sclerosis, and diabetic nephropathy. It is invaluable for screening endothelin receptor antagonists, dissecting post-receptor signaling pathways, and validating small molecule modulators targeting upstream regulators or downstream effectors. Researchers routinely employ Western blotting to assess EDN1 and phosphorylated forms of ERK and p38, RT-qPCR for EDN1 transcript and target gene analysis, calcium imaging to monitor receptor-mediated calcium fluxes, cell proliferation assays, ELISA-based quantification of secreted endothelin-1, luciferase reporter assays for pathway activity, and co-immunoprecipitation to probe receptor?Ccaveolin or arrestin interactions. For additional details and support, please contact Ascent Research.
